i wasn't referring to you but the prices in general and that @Filterthenoise person with 11,000 posts of nothing (one line, same type of message, no analysis, no depth on that poster, probably doesn't read SEC filings, relying on charts, but dilution once realized breaks charts )
1. Price can go less than 0.0001 (look at RNVA, investor buys at .0001 and sells at 0.000001) 2. Market maker makes easy money buys at 0.0001 sells at 0.0002 , and at some point the price goes under 0.0001
3. With current dilution (fully diluted shares 6 Billion), will soon have to amend charter as share count before lock-up of shares/warrants for Biosciences company acquisition expires and get closer to the 2.5 billion shares authorized
Price should already be less than 0.0001 if you do the math
4. Once the next shares authorization is expanded beyond 2.5 billion, maybe Common stockholders wake up to more dilution 5. If investors haven't woken up from #4, then they should wake up when reverse split becomes more than 500:1 , because 500:1 at 0.0002puts stock price only at 0.10 which is not good enough for big-board listing. Foxo will need mucj more than 500:1
6. Foxo share price already in downward spiral. They sure aren't generating billions of income to increase the price per 6 billion shares , so what solutions:
a) they can find ticker #3 and merge all the business of Foxo into ticker #3 (Foxo was ticker #2 for RNVA) b) they can take Foxo Acquisition Corp and make a new ticker for it, then merge the other FOXO business that isn't already in Foxo Acq Corp (ie, the initial two RNVA businesses, the zero insurance business, potentially Foxo Lab biz)
Market Data 
Markets 
AI
